Logging out of EU Login will log you out of any other services that use your EU Login account. Use the CORDIS log out button to remain logged in on other services.
This is a machine translation provided by the European Commission’s eTranslation service to help you understand this page. Please read the conditions of use.
p53 as a New Mediator of Energy Balance in the Brain
Final Report Summary - OBESITY53 (p53 as a New Mediator of Energy Balance in the Brain)
In this project we are evaluating the potential of brain p53 as an anti-obesity and/or anti-diabetic drug candidate. To achieve this, we have designed a strategy that includes genetically-manipulated mice approaches. In this sense, we have found that brain p53 is necessary for the adipogenic action of ghrelin. Moreover, we are now characterizing the metabolic alterations of mice lacking p53 in the whole body and mice lacking p53 in specific neuronal populations which are key in the regulation of energy balance and glucose metabolism. Understanding the precise role and mechanisms regulated by central p53 on energy balance may open new avenues for the identification of potential antiobesity drug targets directed towards specific molecular pathways.